Applying health economics for policy decision making: do devices differ from drugs?

C. Sorenson, R. Tarricone, M. Siebert, M.F. Drummond

Research output: Contribution to journalArticlepeer-review


Medical devices pose unique challenges for economic evaluation and associated decision-making processes that differ from pharmaceuticals. We highlight and discuss these challenges in the context of cardiac device therapy, based on a systematic review of relevant economic evaluations. Key challenges include practical difficulties in conducting randomized clinical trials, allowing for a ‘learning curve’ and user characteristics, accounting for the wider organizational impacts of introducing new devices and allowing for variations in product characteristics and prices over time.
Original languageUndefined/Unknown
Pages (from-to)ii54-ii58
JournalEuropace Spotlight Supplement
Issue numberSUPPL. 2
Publication statusPublished - May 2011


  • Medical devices
  • Cardiology
  • Economic evaluation
  • Health technology assessment

Cite this